Teradyne, Inc. Stock Surpasses Analyst Target: What’s Next?
Recently, shares of Teradyne, Inc. (Symbol: TER) surpassed the average 12-month analyst target price of $138.88, now trading at $140.00 per share. When stocks reach their forecast targets, analysts typically have two primary options: downgrade due to valuation concerns or raise their target price in line with stock performance. Analysts’ decisions may also hinge on the positive business developments influencing the stock’s rise.
Within the Zacks coverage universe, a total of 16 analysts contribute to the average target for Teradyne. However, this average is merely a mathematical mean; some analysts have much lower targets, such as $111.00, while others set their projections as high as $180.00. The standard deviation among these estimates is $19.081.
The rationale behind examining the average target price is to harness the collective insight of numerous analysts, rather than relying on one individual expert’s opinion. With TER now exceeding the average target price of $138.88 per share, investors have a crucial opportunity to evaluate the company’s potential: is $138.88 just a stepping stone to an even higher target, or is it time to consider reducing their holdings? Below is an overview of the current analyst ratings for Teradyne, Inc.:
Recent TER Analyst Ratings Breakdown | ||||
---|---|---|---|---|
» | Current | 1 Month Ago | 2 Months Ago | 3 Months Ago |
Strong buy ratings: | 11 | 10 | 10 | 10 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 4 | 5 | 5 | 5 |
Sell ratings: | 1 | 1 | 1 | 1 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.69 | 1.81 | 1.81 | 1.81 |
The average rating in the table above ranges from 1 to 5, with 1 indicating a Strong Buy and 5 a Strong Sell. This article utilizes data provided by Zacks Investment Research via Quandl.com. Access the latest Zacks research report on TER — for free.
The Top 25 Broker Analyst Picks of the S&P 500 »
Also see:
DNLI Options Chain
PCI Insider Buying
Institutional Holders of SXCL
The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Nasdaq, Inc.